FELZARTAMAB REDUCES aPLA2R Ab BY SELECTIVELY DEPLETING CD38+ PLASMA CELLS AND PLASMABLASTS, THE MAIN PATHOGENIC CELLULAR DRIVERS OF DISEASE IN PRIMARY MEMBRANOUS NEPHROPATHY (PMN)

  Back
FELZARTAMAB REDUCES aPLA2R Ab BY SELECTIVELY DEPLETING CD38+ PLASMA CELLS AND PLASMABLASTS, THE MAIN PATHOGENIC CELLULAR DRIVERS OF DISEASE IN PRIMARY MEMBRANOUS NEPHROPATHY (PMN)
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/829e4b2ea7e6317e359319cf9819396a.pdf
Donna
Flesher
9
Donna Flesher donna.flesher@biogen.com Human Immunology Biosciences, Inc South San Francisco United States
Rainer Boxhammer Rainer.Boxhammer@morphosys.com Morphosys AG Clinical Biomarkers Planegg Germany
Tabea Kräft Tabea.Kraeft@morphosys.com Morphosys AG Clinical Biomarkers Planegg Germany
Lisa Kivman lisa@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Biomarker and Bioanalytical Sciences South San Francisco, CA United States
Lisa Kivman lisa@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Biomarker and Bioanalytical Sciences South San Francisco, CA United States
Stefan Härtle stefan.haertle@morphosys.com Morphosys AG Clinical Pharmacology Planegg Germany
Jaideep Dudani jaidud3@gmail.com Human Immunology Biosciences, Inc, a Biogen Company Portfolio Development South San Francisco, CA United States
Houston Gilbert houston@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Biometrics South San Francisco, CA United States
Uptal Patel uptal@hibio.com Human Immunology Biosciences, Inc, a Biogen Company Clinical Development South San Francisco, CA United States
Brad Rovin Brad.rovin@osumc.edu The Ohio State University Division of Nephrology Columbus, OH United States